Wednesday, 05 Nov 2025

MedPulse360

Opinion: STAT+: The FDA’s absence from international standards meetings threatens U.S. leadership
14 September, 2025

STAT+: Eli Lilly says it will hike list prices for drugs abroad. Now what?
14 September, 2025

Opinion: The CDC shooting was public health’s Jan. 6
14 September, 2025

Draft of major MAHA report calls for more education, less regulation — and offers few policies
14 September, 2025

STAT+: Novo Nordisk’s obesity drug Wegovy cleared to treat MASH
14 September, 2025

STAT+: Pharmalittle: We’re reading about Trump and tariffs, a new pharma lobbying group, and much more
13 September, 2025

How clinicians write about Black patients in the EHR
13 September, 2025

STAT+: U.S. warning on use of ‘march-in’ rights against Harvard seems like distant threat for pharma
13 September, 2025

STAT+: In a financial fix, Sarepta sells Arrowhead stock
13 September, 2025

STAT+: Modified antibody shows promise for treating metastatic cancer, early trial shows
13 September, 2025
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago